Skip to content

Assessment of skin and scar quality after Fat Infiltration

Assessment of skin and scar quality after Fat Grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-43vpmr
Enrollment
Unknown
Registered
2018-08-10
Start date
2016-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of skin quality, improvement of scar tissue

Interventions

Select 10 patients with indication of abdominoplasty and who have cesarean scar, harvest 20ml of fat from the abdomen through liposuction, infiltrate this fat on only one side of the cesarean scar. A
Procedure/surgery
G12.875.545.340

Sponsors

Universidade Federal de Pernambuco - UFPE
Lead Sponsor
Universidade Federal de Pernambuco - UFPE
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Women; abdominoplasty indication; between 20 and 50 years; BMI below 30; previous cesarean scar.

Exclusion criteria

Exclusion criteria: Smokers; patients with systemic disease; use of any medication for chronic use.

Design outcomes

Primary

MeasureTime frame
The two pieces: the previously fat grafted area in the right hemisphere and, analogously, a control area on the other side, that is: another 3 x 3 cm square contralateral sample including the last 3 cm of the cesarean scar will go to analysis in the Pathology Sector of the HC-UFPE where the possible qualitative and quantitative changes of the lipoenxert dermis will be evaluated in relation to the dermis that was not lipografted. By checking whether or not there are changes in the skin of an area that has received fat grafting, attest to whether or not there is changes in the scar tissue that received a fat graft and, if so, to identify what changes have occurred.;Ten patients had a mean age of 35.9 years (standard deviation of 10.1 years) and mean BMI of 24.1 kg / m2 (standard deviation of 3.1 kg / m2). Two surgical specimens were obtained from each patient. Randomly, one specimen was grafted and the other not, resulting in 10 samples from each group. From the samples where the graft was grafted, it was verified the presence of viable grafted adipocytes in all of them. Thus, 50% of the study samples showed signs of successful fat grafting. As for the dermis thickness, it was verified that both the samples that received fat grafting and those that did not received had a high prevalence of a mild inflammatory process (70.0% and 90.0%, respectively). Furthermore, the homogeneity test was not significant (p-value = 0.582), indicating that there was no difference in the inflammatory process between the group of samples that received and did not receive the fat graft. As for the dermis thickness, a higher mean was observed in the group of samples that did not receive fat grafting (mean = 2.27 mm) compared to the fat gratfed group (mean = 2.26 mm). Although the difference was not significant (p-value = 0.973), indicating that the fat graft treatment did not significantly alter the dermis thickness. In relation to the density of vascularization, there was a higher mean in t

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactJuan Maricevich

Universidade Federal de Pernambuco - UFPE

jpmaricevich@gmail.com+55-81-21268000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)